RXO Stockholders Approve 7 Million Share Increase for Incentive Plan

summarizeSummary

RXO stockholders approved an increase of 7 million shares for the company's incentive compensation plan, representing a potential dilution of nearly 5% for existing shareholders.

check_boxKey Events

• Incentive Plan Share Increase Approved

  Stockholders approved an amendment to the 2022 Omnibus Incentive Compensation Plan, authorizing an additional 7 million shares for issuance. If all authorized shares were issued, dilution would be approximately 4.68%.

• Directors Elected

  All eight nominated directors, including Drew Wilkerson and Thomas Szlosek, were elected to the board for a term expiring in 2027.

• Auditor Ratified

  Deloitte & Touche LLP was ratified as the independent registered public accounting firm for fiscal year 2026.

• Executive Compensation Approved

  Stockholders provided advisory approval for the compensation of named executive officers.

auto_awesomeAnalysis

RXO's stockholders approved an amendment to the 2022 Omnibus Incentive Compensation Plan, authorizing the issuance of an additional 7 million shares for employee incentives. This represents a potential dilution of approximately 4.68% for existing shareholders if all these shares are issued. While common for compensation, the magnitude of potential dilution is notable.